ArticleCancers2022

Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG).

Chen Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.